Frontiers | New Insights on CD8+ T Cells in Inflammatory Bowel Disease and Therapeutic Approaches
Challenges in the diagnosis and management of inflammatory bowel disease in resource-limited settings in Asia - The Lancet Gastroenterology & Hepatology
Induced organoids derived from patients with ulcerative colitis recapitulate colitic reactivity | Nature Communications
Tumor Markers - For Cancer Diagnosis and Prognosis - Antigens and Antibodies as Tumor Markers
Level of Tumor Necrosis Factor Production by Stimulated Blood Mononuclear Cells Can Be Used to Predict Response of Patients With
Frontiers | Serum Biomarkers for Inflammatory Bowel Disease
The exercise-induced inflammatory response in inflammatory bowel disease: A systematic review and meta-analysis | PLOS ONE
Other Markers - MBL
PTPN2-LysMCre Mice Are Protected from Colitis-Associated Tumor... | Download Scientific Diagram
From Inflammation to Cancer in Inflammatory Bowel Disease: Molecular Perspectives | Anticancer Research
Cancers Complicating Inflammatory Bowel Disease | NEJM
Frontiers | miRNA-Based Potential Biomarkers and New Molecular Insights in Ulcerative Colitis
Mucosal biomarkers in inflammatory bowel disease: Key pathogenic players or disease predictors?
Detection of Marker Associated with CTC in Colorectal Cancer in Mononuclear Cells of Patients with Benign Inflammatory Intestina
Tumor Markers:- Part 7 - CA 125 and CA 19-9 - Labpedia.net
Low-Fat, High-Fiber Diet Reduces Markers of Inflammation and Dysbiosis and Improves Quality of Life in Patients With Ulcerative Colitis - Clinical Gastroenterology and Hepatology
Inflammatory bowel disease and pregnancy
Serum Biomarkers Identify Patients Who Will Develop Inflammatory Bowel Diseases Up to 5 Years Before Diagnosis - Gastroenterology
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
Frontiers | Glucocorticoid Therapy in Inflammatory Bowel Disease: Mechanisms and Clinical Practice
Metformin for Cardiovascular Protection, Inflammatory Bowel Disease, Osteoporosis, Periodontitis, Polycystic Ovarian Syndrome, Neurodegeneration, Cancer, Inflammation and Senescence: What Is Next? | ACS Pharmacology & Translational Science
Tumor markers- Dr. Enja Amarnath Reddy
